ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
146 hedge funds and large institutions have $725M invested in Intercept Pharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more funds holding
Funds holding: 125 → 146 (+21)
66% less call options, than puts
Call options by funds: $23.1M | Put options by funds: $68.1M
Holders
146
Holding in Top 10
3
Calls
$23.1M
Puts
$68.1M
Top Buyers
| 1 | +$44.6M | |
| 2 | +$40.8M | |
| 3 | +$37.1M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$30.4M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$27.5M |
Top Sellers
| 1 | -$48.6M | |
| 2 | -$18.9M | |
| 3 | -$18.2M | |
| 4 |
CP
Caligan Partners
New York
|
-$14.3M |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$10.4M |
